×

Diagnosis & Therapy

Vaccine may restore NSCLC response to checkpoint inhibitors

Vaccine may restore NSCLC response to checkpoint inhibitors

Vaccine may restore NSCLC response to checkpoint inhibitorsBY CHRISTINE KILGORE MDedge News SAN FRANCISCO – An experimental allogeneic cellular vaccine combined with the checkpoint inhibitor nivolumab (Opdivo) may boost the immune response in patients with previously...

read more
Neoadjuvant atezolizumab shrinks NSCLC tumors

Neoadjuvant atezolizumab shrinks NSCLC tumors

Neoadjuvant atezolizumab shrinks NSCLC tumorsBY CHRISTINE KILGORE MDedge News SAN FRANCISCO – One-fifth of patients with resectable non–small cell lung cancer had a major pathologic response to neoadjuvant therapy with the immune checkpoint inhibitor atezolizumab...

read more

Continue Reading


Biomarkers


+

Prevention


+

Cost And Coping


+

Diagnosis and Therapy


+

Patient Journey


+